Dendritic Cell-Based Immunity: Screening of Dendritic Cell Subsets in Breast Cancer-Bearing Mice

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Breast cancer (BC) is a leading cause of cancer death in women worldwide.
• Tumor progression is influenced by tumor cell alterations and the immune system within the tumor microenvironment.
• T-cell and dendritic cell (DC) interactions are crucial for anti-tumor immunity but poorly understood during tumor development.

Purpose of the Study:

• To investigate the immune system's response to breast cancer in a mouse model.
• To analyze the phenotypic profiles of T-cells and DCs in BC-bearing mice.
• To quantify key cytokine levels associated with anti-tumor immunity.

Main Methods:

• Breast cancer was induced in BALB/C mice using MDA231 cells.
• Tumor size and volume were monitored.
• Flow cytometry assessed T-cell and DC surface markers.
• ELISA measured cytokine levels (TGF-β, IFN-γ, IL-2, IL-10, IL-4, IL-12, TNF-α) in lymph node and spleen cultures.

Main Results:

• BC induction led to inhibited DC maturation and an accumulation of immature DCs.
• Immature DCs showed increased TGF-β and IL-10, with decreased IFN-γ and IL-12 production.
• Reduced expression of CD80 and CD86 on DCs indicated impaired maturation.

Conclusions:

• The tumor microenvironment likely inhibits DC maturation, weakening the anti-tumor immune response.
• Overexpression of TGF-β and tumor cell stimulation contribute to immature DC accumulation.
• Altered cytokine secretion (increased IL-10, decreased IFN-γ/IL-12) in tumor-bearing mice facilitates tumor proliferation.